Science & Technology

As the spectrum of bioconjugates expands, consistency in the manufacturing process is becoming more important than ever to ensure that therapies meet specifications in a predictable manner while maintaining efficacy. Join Cassandra Barnes (LOTTE Biologics, Snr Scientist) as she discusses LOTTE Biologics' experience in optimizing conjugation. This webinar will address LOTTE Biologics' process and analytical development expertise to ensure desired attributes such as targeted DAR, low aggregation, preserved binding, high purity, enhanced potency and expected structural features.

For full access to this content, please click the link below:

Optimizing Outcomes In ADC Manufacturing